Results 51 to 60 of about 9,371 (163)

Update on the advances and challenges in bioequivalence testing methods for complex topical generic products

Frontiers in Pharmacology
Most of the government regulatory agencies, including the United States Food and Drug Administration and the European Medicine Agency, demand that the generic complex topical products prove pharmaceutical and bioequivalence.
Nedaa Alomari, Waleed Alhussaini
doaj   +1 more source

Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets

Pharmaceutics
As the field of personalized dosing develops, the pharmaceutical manufacturing industry needs to offer flexibility in terms of tailoring the drug release and strength to the individual patient’s needs.
Olha Shuklinova, Gabriela Wyszogrodzka-Gaweł, Ewelina Baran, Bartosz Lisowski, Barbara Wiśniowska, Przemysław Dorożyński, Piotr Kulinowski, Sebastian Polak   +7 more
doaj   +1 more source

Highly variable medicines - specific aspects of bioequivalence studies

Регуляторные исследования и экспертиза лекарственных средств, 2018
At present a specific group of medicines - highly variable medicines - is distinguished based on intraindividual variability data (CVintra > 30%). It is quite difficult to confirm therapeutic equivalence of highly variable medicines by pharmacokinetic ...
D. P. Romodanovsky, T. V. Eremenkova, M. A. Dranitsyna, D. V. Goryachev, R. R. Niyazov, E. V. Gavrishina, V. A. Merkulov   +6 more
doaj  

Demystifying bioequivalence [PDF]

Medical Journal of Australia, 2014
openaire   +2 more sources

bioequivalence

Citation: 'bioequivalence' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.15154 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms. Requests for commercial
openaire   +1 more source

Bioequivalence and Bioequivalency Testing

American Journal of Pharmaceutical Education, 1999
openaire   +1 more source

Problems of bioanalytical part of bioequivalence studies of drugs in Russia

Фармакокинетика и Фармакодинамика, 2014
In the review of the main problems holding bioanalytical part of bioequivalence studies of medicines in Russia. The analysis of the major causes of failure when performing studies of bioequivalence and pharmacokinetics.
A. L. Khokhlov, E. G. Lileeva, O. A. Sinitsyna, S. A. Speshilova, S. M. Demarina, L. N. Shitov   +5 more
doaj  

Bioequivalence of a Fixed-Dose Combination of Relugolix, Estradiol, and Norethindrone Acetate: An Open-Label, Randomized, Fully Replicate Crossover Study in Healthy Postmenopausal Women Under Fasting Conditions. [PDF]

Clin Pharmacol Drug Dev
Kotadia R, Kumar S, Khuroo A, Dharmadhikari S, Shahi P, Narayana GNVSS, Reyar S.   +6 more
europepmc   +1 more source

Comparative bioequivalence of 1 mg and 4 mg tacrolimus extended-release tablets: randomized, open label, fully replicate, crossover trials in healthy adult subjects. [PDF]

Front Nephrol
Sharma JK, Bunger D, Zaveri H, Chaturvedi A.   +3 more
europepmc   +1 more source

Exploring the association between pharmacy curricular tracks and students' attitudes toward generic medicines: insights from a comparative study in Egypt. [PDF]

Front Pharmacol
Sawan ES, Mostafa M, Sayed YT, Binsaleh AY, Mohamed MA, Hussein RRS.   +5 more
europepmc   +1 more source